Serum fibroblast growth factor 19 is decreased in patients with overt hypothyroidism and subclinical hypothyroidism

As a newly emerging metabolic regulator, accumulating evidence suggests that the circulating fibroblast growth factor 19 (FGF19) level correlated with lipid and glucose metabolism. Several independent groups have found that FGF19 was highly likely associated with multiple metabolic disorders. Thyroi...

Descripción completa

Detalles Bibliográficos
Autores principales: Lai, Yaxin, Wang, Haoyu, Xia, Xinghai, Wang, Zhaojun, Fan, Chenling, Wang, Hong, Zhang, Hongmei, Ding, Shuangning, Teng, Weiping, Shan, Zhongyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
4300
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5265952/
https://www.ncbi.nlm.nih.gov/pubmed/27684859
http://dx.doi.org/10.1097/MD.0000000000005001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5265952/
https://www.ncbi.nlm.nih.gov/pubmed/27684859
http://dx.doi.org/10.1097/MD.0000000000005001

Ejemplares similares